Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection

Table 2

Multiple logistic regression analysis of a recurrence and/or persistence of DME after STTA.

Factors	Recurrence (+)	Recurrence (−)	Odds ratio	95% CI	value
Sex, men : women ()	42 : 32	29 : 21	0.718	0.034–0.973	0.4846
Mean age (y.o.)	61.6 ± 13.0	58.5 ± 13.2	1.012	0.978–1.049	0.4883
Mean HbA1c (%)	6.83 ± 1.32	6.59 ± 1.09	1.239	0.833–1.843	0.2906
Hypertension, + : −	38 : 36	17 : 33	1.926	0.760–4.879	0.1669
Insulin use, + : − ()	24 : 50	14 : 36	1.367	0.525–3.562	0.5218
Pioglitazone use, + : − ()	8 : 66	2 : 48	2.416	0.373–15.628	0.3544
Proteinuria, + : − ()	30 : 44	17 : 33	1.103	0.420–2.894	0.8422
Mean BCVA (logMAR)	0.61 ± 0.37	0.52 ± 0.33	2.054	0.523–8.065	0.3022
Mean CMT (m)	557.2 ± 143.7	512.8 ± 172.2	1.002	0.999–1.005	0.1800
SRD, + : − ()	22 : 52	11 : 39	1.012	0.370–2.769	0.9821
MAPC, + : − ()	35 : 39	14 : 36	2.566	1.087–6.058	0.0315
SMDLP, + : − ()	11 : 63	2 : 48	7.772	1.098–55.004	0.0400
PRP, + : − ()	33 : 41	22 : 28	0.951	0.390–2.321	0.9124
Vitrectomy, + : − ()	7 : 67	10 : 40	0.182	0.034–0.973	0.0464
Cataract surgery, + : − ()	15 : 59	10 : 40	1.355	0.336–5.460	0.6691

BCVA: best-corrected visual acuity, CMT: central macular thickness, SRD: serous retinal detachment, MAPC: microaneurysm photocoagulation, SMDLP: subthreshold micropulse diode laser photocoagulation, and PRP: panretinal photocoagulation.